Clinical trials: sponsored by Xuanwu Hospital, Beijing
Adverse Event
Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting
This is a prospective single-center,randomized controlled trial,aiming to investigate the safety and efficacy of distal EPD in vertebral artery origin stenting(VAOS);256 subjects will be recruited in this study,after randomized…
- Trial name
- NCT03381534
- Testing
- stenting with EPD, stent assisted angioplasty
- Where
- China
- Volunteers
- 256 people
- Sponsor
- Xuanwu Hospital, Beijing
Cerebral Revascularization, Ischemic Cerebrovascular Disease
The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization
Objective: Referring The relation between CEA(Carotid endarterectomy) postoperative blood flow monitoring and blood pressure, and combining patient demographics and preoperative risk factors to establish an applicable individual…
- Trial name
- NCT03256513
- Testing
- model controlling, conventional controlling
- Where
- China
- Volunteers
- 2,270 people
- Sponsor
- Xuanwu Hospital, Beijing
Basilar Invagination Associated With Atlantoaxial Dislocation
Posterior Compression Distraction Reduction Technique System in the Treatment of BI-AAD
Posterior compression distraction reduction technique （PCDR） in the treatment of Basilar invagination associated with atlantoaxial dislocation
- Trial name
- PCDR-BIAAD (NCT03070743)
- Testing
- Posterior Approach Compression Distraction Reduction Surgery
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Xuanwu Hospital, Beijing
Myocardial Infarction
Long-term Remote Ischemic Preconditioning Improve Long-term Prognosis of Acute Myocardial Infarction Patients Without Emergency Reperfusion Therapy
Patients with acute myocardial infarction (AMI) are in critical condition especially without emergency reperfusion therapy. For example, heart failure, heart rupture, malignant arrhythmia are in high level.
- Trial name
- NCT02843464
- Testing
- reported remote ischemic preconditioning (RIPC)
- Volunteers
- 220 people
- Sponsor
- Xuanwu Hospital, Beijing
Myocardial Infarction, Acute
Long-term Remote Ischemic Preconditioning Improve the Prognosis of Myocardial Infarction Patients With Emergency Reperfusion Therapy
Patients with acute myocardial infarction (AMI) are in critical condition. When primary percutaneous coronary intervention (PCI) was performing, no-reflow, reperfusion injury，heart failure, heart rupture, malignant arrhythmia…
- Trial name
- NCT03018873
- Testing
- remote ischemic preconditioning （RIPC）
- Volunteers
- 400 people
- Sponsor
- Xuanwu Hospital, Beijing
Stroke
Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study
The purpose of this multicenter study is to investigate the extra-/intra-cranial atherosclerosis distribution pattern in chinese populations with transient ischemic attack and ischemic stroke and analyze the influencing factors…
- Trial name
- NCT02397655
- Where
- China
- Volunteers
- 12,012 people
- Sponsor
- Xuanwu Hospital, Beijing
Ischemic Stroke
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting
- Trial name
- NCT02197559
- Testing
- DES group, BMS group
- Where
- China
- Volunteers
- 168 people
- Sponsor
- Xuanwu Hospital, Beijing
Alzheimer's Disease
The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI
Alzheimer's disease (AD) is one of the major brain diseases which received more attention in recent years. The disconnection syndrome is the main pathophysiological mechanism leading to cognitive decline in AD patients.
- Trial name
- NCT02759159
- Testing
- true acupuncture
- Where
- 2 sites in China
- Volunteers
- 120 people
- Sponsor
- Xuanwu Hospital, Beijing
Atherosclerosis, Ischemia
Clinical Study of Stent Versus Direct Atherectomy to Treat Lower Limb Ischemia
This is a randomized study comparing stent and plaque excision systems in treatment of lower limb (superficial femoral or popliteal artery) ischemia.
- Trial name
- NCT02514460
- Testing
- plaque excision system, Stent
- Where
- China
- Volunteers
- 120 people
- Sponsor
- Xuanwu Hospital, Beijing
Aneurysm, Intracranial, Carotid-Cavernous Sinus Fistula
New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry
The purpose of this study is to evaluate the effectiveness, long-term safety and explore the safety and efficacy factors WILLIS™ intracranial stent graft system in clinical applications.
- Trial name
- COVER (NCT02820779)
- Testing
- WILLIS
- Where
- 11 sites in China
- Volunteers
- 100 people
- Sponsor
- Xuanwu Hospital, Beijing
Basilar Invagination Associated With Atlantoaxial Dislocation
Posterior Compression Distraction Reduction （CDR）Technique in the Treatment of BI-AAD
Posterior compression - distraction reduction technique （CDR） in the treatment of Basilar invagination associated with atlantoaxial dislocation
- Trial name
- CDR (NCT02463630)
- Testing
- Posterior Approach Compression Distraction Reduction
- Where
- China
- Volunteers
- 22 people
- Sponsor
- Xuanwu Hospital, Beijing
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders
Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
The treatment protocol consisted of 12 mg/m2 MITO intravenous infusions every 3 months for 2 years. Dosage was adjusted according to side effects.
- Trial name
- NCT02021825
- Testing
- Mitoxantrone
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Xuanwu Hospital, Beijing
Carotid Stenosis, Surgery
Revascularization of Extracranial Carotid Artery Stenosis
Investigate the current situation of carotid stenosis therapy in China. Establish the data bank of carotid stenosis revascularization (CAS and CEA) in China ,in order to get best quality control of the therapy, as well as confirm…
- Conditions
- Carotid Stenosis, Surgery, Stroke
- Trial name
- RECAS (NCT01994187)
- Testing
- Carotid endarterectomy, carotid angioplasty
- Where
- China
- Volunteers
- 2,100 people, healthy volunteers welcome
- Sponsor
- Xuanwu Hospital, Beijing
Ischemic Stroke
Clinical Registration Trial of Intracranial Stenting for Patients With Symptomatic Intracranial Artery Stenosis(CRTICAS)
This trial is an prospective, government-funded registration study that will observe the safety and effectiveness of intracranial stenting for preventing stroke during a mean follow-up of 12 months in patients with symptomatic…
- Trial name
- NCT01994161
- Testing
- intracranial stenting
- Where
- China
- Volunteers
- 840 people
- Sponsor
- Xuanwu Hospital, Beijing
Critical Limb Ischemia, Peripheral Arterial Disease
Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
Using autologous bone marrow mononuclear cells (BM-MNC) to treat patients with chronic limb ischemia has been proved safe and effective.
- Conditions
- Critical Limb Ischemia, Peripheral Arterial Disease, Buerger's Disease
- Trial name
- NCT01446055
- Testing
- ResQ processed bone marrow sample, Ficoll conventional cell processing method
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Xuanwu Hospital, Beijing
Parkinson's Disease
Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients
The purpose of this study is to determine whether Green Tea Polyphenol, an extraction from Green Tea is effective and safe in the treatment of De Novo Parkinson's disease Patients without taking any antiparkinsonism drug
- Trial name
- NCT00461942
- Testing
- Green Tea Polyphenols (EGCG/ECG)
- Where
- China
- Volunteers
- 480 people
- Sponsor
- Xuanwu Hospital, Beijing
Parkinson's Disease
Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease
The purpose of this study is to determine whether Lingzhi (Ganoderma), a widely used traditional Chinese Medicine is effective and safe in the treatment of Parkinson's disease when combined use with L-dopa.
- Trial name
- NCT00224263
- Testing
- Lingzhi (Ganoderma)
- Where
- China
- Volunteers
- 360 people
- Sponsor
- Xuanwu Hospital, Beijing
Depression in Parkinson's Disease
Treatment of Depression in Parkinson's Disease
The goal of this study is to evaluate the efficacy of Traditional Chinese Medicine-"Xiaoyao Pill" (Herb extracts)on depression, compared to placebo and "Bupleurum+Ginkgo" in patients with Parkinson's disease.
- Trial name
- NCT01416818
- Testing
- Xiaoyao Pill, Bupleurum+Ginkgo
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Xuanwu Hospital, Beijing